Weizhou Wu

1.0k total citations
34 papers, 581 citations indexed

About

Weizhou Wu is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Epidemiology. According to data from OpenAlex, Weizhou Wu has authored 34 papers receiving a total of 581 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Pulmonary and Respiratory Medicine, 12 papers in Molecular Biology and 9 papers in Epidemiology. Recurrent topics in Weizhou Wu's work include Kidney Stones and Urolithiasis Treatments (12 papers), Pediatric Urology and Nephrology Studies (5 papers) and Urinary Tract Infections Management (5 papers). Weizhou Wu is often cited by papers focused on Kidney Stones and Urolithiasis Treatments (12 papers), Pediatric Urology and Nephrology Studies (5 papers) and Urinary Tract Infections Management (5 papers). Weizhou Wu collaborates with scholars based in China, Sweden and United Kingdom. Weizhou Wu's co-authors include Shankun Zhao, Tao Zeng, Wenqi Wu, Miguel Á. Sanz, R.A. Barnes, Fangling Zhong, Andrea Tramarin, Andrew J. Ullmann, B. Gerlach and Karl J. Krobot and has published in prestigious journals such as PLoS ONE, Clinical Infectious Diseases and Biochemical and Biophysical Research Communications.

In The Last Decade

Weizhou Wu

34 papers receiving 573 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Weizhou Wu China 15 219 157 121 108 95 34 581
Feng Zeng China 19 374 1.7× 297 1.9× 88 0.7× 262 2.4× 188 2.0× 76 991
Behzad Narouie Iran 17 139 0.6× 229 1.5× 107 0.9× 88 0.8× 167 1.8× 88 769
Noël Knops Belgium 11 114 0.5× 212 1.4× 56 0.5× 163 1.5× 18 0.2× 31 649
Jeong Hyun Kim South Korea 19 315 1.4× 86 0.5× 60 0.5× 54 0.5× 40 0.4× 61 732
Antonios Marmarinos Greece 17 82 0.4× 186 1.2× 97 0.8× 215 2.0× 71 0.7× 61 739
Orhan Göğüş Türkiye 19 417 1.9× 183 1.2× 52 0.4× 157 1.5× 67 0.7× 62 987
Alexandru Cărăuleanu Romania 11 60 0.3× 62 0.4× 105 0.9× 136 1.3× 17 0.2× 80 591
Jan Janota Czechia 16 142 0.6× 147 0.9× 185 1.5× 97 0.9× 24 0.3× 55 613
Rajeev Shukla United Kingdom 14 99 0.5× 181 1.2× 75 0.6× 31 0.3× 43 0.5× 54 674
Kristien J. Ledeganck Belgium 14 73 0.3× 186 1.2× 54 0.4× 45 0.4× 179 1.9× 34 830

Countries citing papers authored by Weizhou Wu

Since Specialization
Citations

This map shows the geographic impact of Weizhou Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weizhou Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weizhou Wu more than expected).

Fields of papers citing papers by Weizhou Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Weizhou Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weizhou Wu. The network helps show where Weizhou Wu may publish in the future.

Co-authorship network of co-authors of Weizhou Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Weizhou Wu. A scholar is included among the top collaborators of Weizhou Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Weizhou Wu. Weizhou Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zeng, Tao, Weizhou Wu, Liangwei Zhang, et al.. (2023). Superselective renal arterial embolization for severe postpercutaneous nephrolithotomy haemorrhage: clinical characteristics and risk factors for initial failure. World Journal of Urology. 41(6). 1647–1652. 1 indexed citations
2.
Jin, Tingting, et al.. (2022). Hypospadias and Increased Risk for Psychiatric Symptoms in Both Childhood and Adolescence: A Literature Review. Frontiers in Psychiatry. 13. 799335–799335. 6 indexed citations
3.
Xie, Jie, et al.. (2022). Roles of MicroRNA-21 in Skin Wound Healing: A Comprehensive Review. Frontiers in Pharmacology. 13. 828627–828627. 47 indexed citations
4.
Wu, Weizhou, et al.. (2022). MicroRNA-31: a pivotal oncogenic factor in oral squamous cell carcinoma. Cell Death Discovery. 8(1). 140–140. 18 indexed citations
5.
Wu, Weizhou, et al.. (2022). Risk of osteoporosis and fracture after hysterectomies without oophorectomies: a systematic review and pooled analysis. Osteoporosis International. 33(8). 1677–1686. 6 indexed citations
6.
Zhao, Shankun, et al.. (2022). Protective effects of dexmedetomidine in vital organ injury: crucial roles of autophagy. Cellular & Molecular Biology Letters. 27(1). 34–34. 27 indexed citations
7.
Zhao, Shankun, et al.. (2022). Molecular mechanisms underlying the renal protective effects of coenzyme Q10 in acute kidney injury. Cellular & Molecular Biology Letters. 27(1). 57–57. 17 indexed citations
8.
Zhao, Shankun, et al.. (2022). Roles of ARID1A variations in colorectal cancer: a collaborative review. Molecular Medicine. 28(1). 42–42. 16 indexed citations
10.
Wu, Weizhou, et al.. (2021). Chronic Hepatitis Virus Infection Are Associated With High Risk of Gastric Cancer: A Systematic Review and Cumulative Analysis. Frontiers in Oncology. 11. 703558–703558. 12 indexed citations
11.
Zhao, Shankun, Weizhou Wu, Hao Jiang, et al.. (2021). Selective Inhibitor of the c-Met Receptor Tyrosine Kinase in Advanced Hepatocellular Carcinoma: No Beneficial Effect With the Use of Tivantinib?. Frontiers in Immunology. 12. 731527–731527. 17 indexed citations
12.
Zhao, Shankun, Weizhou Wu, Pan Wang, et al.. (2021). ARID1A Variations in Cholangiocarcinoma: Clinical Significances and Molecular Mechanisms. Frontiers in Oncology. 11. 693295–693295. 13 indexed citations
13.
Zhao, Shankun, et al.. (2021). Roles of ferroptosis in urologic malignancies. Cancer Cell International. 21(1). 676–676. 33 indexed citations
14.
Zhao, Shankun, et al.. (2021). Significant Increase of Erectile Dysfunction in Men With Post-stroke: A Comprehensive Review. Frontiers in Neurology. 12. 671738–671738. 6 indexed citations
15.
Zhao, Shankun, Weizhou Wu, Ran Kang, & Xiaolan Wang. (2021). Significant Increase in Depression in Women With Primary Dysmenorrhea: A Systematic Review and Cumulative Analysis. Frontiers in Psychiatry. 12. 686514–686514. 22 indexed citations
16.
Zhang, Shike, Yapeng Huang, Weizhou Wu, et al.. (2021). Trends in urinary stone composition in 23,182 stone analyses from 2011 to 2019: a high-volume center study in China. World Journal of Urology. 39(9). 3599–3605. 14 indexed citations
17.
Zhong, Fangling, Weizhou Wu, Dong Chen, et al.. (2021). The characteristic and relationship of Escherichia coli isolated from urine and stones in patients with calcium oxalate stones. Urolithiasis. 49(5). 407–414. 6 indexed citations
18.
Wu, Weizhou, et al.. (2019). A new molecular probe: An NRP-1 targeting probe for the grading diagnosis of glioma in nude mice. Neuroscience Letters. 714. 134617–134617. 9 indexed citations
19.
Lai, Yongchang, Xiongfa Liang, Fangling Zhong, et al.. (2018). Allicin attenuates calcium oxalate crystal deposition in the rat kidney by regulating gap junction function. Journal of Cellular Physiology. 234(6). 9640–9651. 16 indexed citations
20.
Ullmann, Andrew J., Miguel Á. Sanz, Andrea Tramarin, et al.. (2006). Prospective Study of Amphotericin B Formulations in Immunocompromised Patients in 4 European Countries. Clinical Infectious Diseases. 43(4). e29–e38. 78 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026